InspireMD, Inc.
InspireMD, Inc.（NSPR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NSPR · 截至 2026年6月9日
活动摘要
买入笔数
19
P-Purchase only
卖出笔数
12
近12个月
买卖比
1.58
Buy/Sell (by trades)
整体情绪
InspireMD, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
NSPR 季度内部人买卖趋势
NSPR 内幕交易卖出 · NSPR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · NSPR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NSPR 高管卖出股份 · NSPR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 27, 2026 | Stuka Paul Director | Purchase | 20,000 | $18K | Form 4 |
| Jan 27, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 3,858 | $10K | Form 4 |
| Jan 28, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 2,476 | $6K | Form 4 |
| Jan 29, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 3,660 | $9K | Form 4 |
| Jan 30, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 2,454 | $6K | Form 4 |
| Jan 31, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 9,923 | $25K | Form 4 |
| Feb 3, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 7,073 | $18K | Form 4 |
| Feb 4, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 5,132 | $13K | Form 4 |
| Feb 25, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 10,000 | $37K | Form 4 |
| May 23, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 2,482 | $6K | Form 4 |
| May 27, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 1,572 | $4K | Form 4 |
| May 29, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 3,760 | $9K | Form 4 |
| May 30, 2025 | Gleason Shane Thomas Chief Commercial Officer | Sale | 7,186 | $18K | Form 4 |
| Feb 2, 2026 | Gleason Shane Thomas Chief Commercial Officer | Sale | 2,941 | $5K | Form 4 |
| May 19, 2026 | Gleason Shane Thomas Chief Commercial Officer | Sale | 22,778 | $23K | Form 4 |
| May 14, 2026 | Stuka Paul Director | Purchase | 5,000 | $6K | Form 4 |
| May 13, 2026 | Stuka Paul Director | Purchase | 10,000 | $12K | Form 4 |
| May 12, 2026 | Slosman Marvin CEO and President · Director | Purchase | 21,000 | $25K | Form 4 |
| May 11, 2026 | Stuka Paul Director | Purchase | 10,000 | $12K | Form 4 |
| May 8, 2026 | Stuka Paul Director | Purchase | 65,626 | $76K | Form 4 |
| May 7, 2026 | Ward Scott R. Director | Purchase | 73,255 | $84K | Form 4 |
| May 6, 2026 | Ward Scott R. Director | Purchase | 15,995 | $18K | Form 4 |
| May 7, 2026 | Stuka Paul Director | Purchase | 6,378 | $7K | Form 4 |
| May 6, 2026 | Stuka Paul Director | Purchase | 1,517 | $2K | Form 4 |
| May 7, 2026 | ROUBIN GARY S Director | Purchase | 90,000 | $106K | Form 4 |
Gleason Shane Thomas
Chief Commercial Officer
日期
Feb 25
股数
10,000
均价
$3.65
总金额
$37K
Gleason Shane Thomas
Chief Commercial Officer
日期
May 19
股数
22,778
均价
$1.01
总金额
$23K
Slosman Marvin
CEO and President · Director
日期
May 12
股数
21,000
均价
$1.20
总金额
$25K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NSPR 内幕交易
NSPR 内幕交易
InspireMD, Inc.（NSPR）内幕交易数据来源于公司内部人（包括Stuka Paul (Director), Gleason Shane Thomas (Chief Commercial Officer), ROUBIN GARY S (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。NSPR内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看InspireMD, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NSPR 内幕交易 · 5个问题InspireMD, Inc.（NSPR）的内部人包括高管和董事，如Stuka Paul (Director), Gleason Shane Thomas (Chief Commercial Officer), ROUBIN GARY S (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026